c.i. 42510 has been researched along with Hepatitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geraghty, NJ; Sluyter, R; Watson, D | 1 |
1 other study(ies) available for c.i. 42510 and Hepatitis
| Article | Year |
|---|---|
Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatitis; Leukocytes; Liver; Mice; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes | 2019 |